Oppenheimer & Co’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,875
| Closed | -$126K | – | 1666 |
|
|
2024
Q4 | $126K | Buy |
+11,875
| New | +$126K | ﹤0.01% | 1500 |
|
|
2024
Q3 | – | Sell |
-19,323
| Closed | -$324K | – | 1584 |
|
|
2024
Q2 | $324K | Buy |
+19,323
| New | +$324K | 0.01% | 1164 |
|
|
2023
Q2 | – | Sell |
-10,301
| Closed | -$95.2K | – | 1480 |
|
|
2023
Q1 | $95.2K | Sell |
10,301
-210
| -2% | -$1.94K | ﹤0.01% | 1321 |
|
|
2022
Q4 | $93.2K | Buy |
+10,511
| New | +$93.2K | ﹤0.01% | 1294 |
|
|
2020
Q3 | – | Sell |
-11,505
| Closed | -$301K | – | 1345 |
|
|
2020
Q2 | $301K | Buy |
+11,505
| New | +$301K | 0.01% | 969 |
|